Ticker

Analyst Price Targets — SLGL

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
October 27, 2025 10:48 amRaghuram SelvarajuH.C. Wainwright$50.00$39.50StreetInsider Sol Gel Technologies Ltd. (SLGL) PT Raised to $50 at H.C. Wainwright
April 25, 2022 11:19 amH.C. Wainwright$21.00$6.96Benzinga HC Wainwright & Co. Maintains Buy on Sol-Gel Technologies, Raises Price Target to $21

Latest News for SLGL

Sol-Gel Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Sol-Gel received a Notice of Allowance for a method-of-use patent extending intellectual property protection for topical patidegib (SGT-610) until 2044 Sol-Gel completed an oversubscribed underwritten offering, raising gross proceeds of approximately $33.1 million from leading healthcare specialist investors Pivotal Phase 3 clinical trial of SGT-610 (patidegib gel, 2%) for Gorlin syndrome remains ongoing, with…

GlobeNewsWire • May 28, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for SLGL.

No House trades found for SLGL.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top